Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
Actual shortage: | 217 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-02 | 2023-01-26 | 176942 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-09 | 2023-01-26 | 177615 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122465 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122468 |
APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-10-28 | 2021-05-10 | 127328 |
APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2021-02-19 | 2021-05-10 | 134427 |
APO-ALLOPURINOL TABLETS | 300MG | TABLET | Resolved | 2024-11-15 | 2024-11-29 | 243187 |
APO-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2017-03-10 | 2019-05-14 | 24 |
APO-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2017-03-10 | 2019-05-14 | 27 |
APO-ALPRAZ | 1MG | TABLET | Resolved | 2018-04-16 | 2018-10-15 | 46015 |
APO-ALPRAZ | .5MG | TABLET | Resolved | 2018-05-02 | 2018-11-02 | 47950 |
APO-ALPRAZ | 0.25MG | TABLET | Resolved | 2018-07-04 | 2018-10-12 | 54165 |
APO-ALPRAZ | 0.25MG | TABLET | Resolved | 2018-12-27 | 2019-09-16 | 70520 |
APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-03-05 | 2019-09-05 | 77869 |
APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-03-06 | 2019-09-09 | 77974 |
APO-ALPRAZ | 0.25MG | TABLET | Resolved | 2019-03-20 | 2019-09-16 | 79036 |
APO-ALPRAZ | 1MG | TABLET | Resolved | 2019-04-24 | 2019-08-02 | 82331 |
APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-09-09 | 2019-09-16 | 93262 |
APO-ALPRAZ | 0.5MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223546 |
APO-ALPRAZ | 0.5MG | TABLET | Resolved | 2024-08-01 | 2024-09-27 | 234286 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |